KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Change in Intangibles (2018 - 2025)

Historic Change in Intangibles for Jazz Pharmaceuticals (JAZZ) over the last 9 years, with Q3 2025 value amounting to $30.0 million.

  • Jazz Pharmaceuticals' Change in Intangibles changed N/A to $30.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.0 million, marking a year-over-year change of. This contributed to the annual value of $25.0 million for FY2022, which is 3973.51% up from last year.
  • Jazz Pharmaceuticals' Change in Intangibles amounted to $30.0 million in Q3 2025.
  • Over the past 5 years, Jazz Pharmaceuticals' Change in Intangibles peaked at $30.0 million during Q3 2025, and registered a low of $17.9 million during Q3 2021.
  • Its 3-year average for Change in Intangibles is $24.5 million, with a median of $25.0 million in 2022.